Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer.

Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer. Clin Transl Radiat Oncol. 2020 Sep;24:10 Authors: Yamazaki H, Masui K, Suzuki G, Yoshida K PMID: 32596516 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/32596516?dopt=Abstract

Source: Clinical Prostate Cancer - July 1, 2020 Category: Cancer & Oncology Authors: Yamazaki H, Masui K, Suzuki G, Yoshida K Tags: Clin Transl Radiat Oncol Source Type: research

More News: Brachytherapy | Cancer | Cancer & Oncology | Prostate Cancer